6-K

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of July, 2022

(Commission File No. 001-41157)

 

BIONOMICS LIMITED

(Translation of registrant’s name into English)

 

200 Greenhill Road

Eastwood SA 5063

Tel: +618 8150 7400

(Address of registrant’s principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):

Yes ☐ No ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):

Yes ☐ No ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☐

 

 

 


 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

 

On July 20, 2022, the Company lodged a Notification of Issue of Unquoted Equity Securities in relation to the issue of unlisted options under an employee incentive plan on Appendix 3G with the ASX, as required by the laws and regulations of Australia, to disclose a change in interests in securities and contracts of the Company. The Notification of Issue of Unquoted Securities is furnished herewith as Exhibit 99.1 to this report on Form 6-K.

1


 

EXHIBIT INDEX

 

 

 

Exhibit

 

Description

 

99.1

Appendix 3G_Notification of Issue Conversion or Payment up of Unquoted Equity Securities

 

 

 

2


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

 

 

 

Bionomics Limited

 

(Registrant)

 

 

 

 

By:

/s/ Errol De Souza

 

 

Name:

Errol De Souza, Ph.D.

 

Title:

Executive Chairman

Date: July 20, 2022

 

1


EX-99.1

Exhibit 99.1

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_0.jpg 

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

 

Announcement Summary

Entity name

BIONOMICS LIMITED

Date of this announcement
Wednesday July 20, 2022

The +securities the subject of this notification are:

 

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_1.jpg+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

Total number of +securities to be issued/transferred

 

 

 

ASX +security

code Security description

BNOAO OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Total number of

+securities to be

issued/transferred Issue date

7,700,000 15/07/2022

 

Refer to next page for full details of the announcement

 

 


Exhibit 99.1

 

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_2.jpg 

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

 

Part 1 - Entity and announcement details

1.1 Name of entity
BIONOMICS LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_3.jpg 

1.2 Registered number type ABN 53075582740

1.3 ASX issuer code BNO

1.4 The announcement is

New announcement

1.5 Date of this announcement 20/7/2022

Notification of Issue, Conversion or Payment up of Unquoted 2 / 7

 

 


Exhibit 99.1

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_4.jpg 

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

 

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_5.jpg+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and

which:

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_6.jpghas an existing ASX security code ("existing class")

 

 


Exhibit 99.1

 

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_7.jpg 

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

 

Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3Bhttps://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_8.jpg

ASX +security code and description

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Date the +securities the subject of this notification were issued
15/7/2022

Will these +securities rank equally in all respects from their issue date with the existing issued

+securities in that class

Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate?

Yes

Provide details of the KMP or +associates being issued +securities.

Name of KMP Name of registered holder Number of +securities

Adrian Hinton 2,000,000

Connor Bernstein 3,500,000

Elizabeth Doolin 2,000,000

 

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

A summary of the terms of the Employee Incentive Scheme were included in the Notice of Meeting lodged with ASX on 1 November 2021 at https://www.asx.com.au/asxpdf/20211101/pdf/452ftb7z9qmh00.pdf and approved by shareholders on 2 December 2021.

Any other information the entity wishes to provide about the +securities the subject of this notification

Notification of Issue, Conversion or Payment up of Unquoted 4 / 7

 

 


Exhibit 99.1

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_9.jpg 

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

 

Issue details

Number of +securities
7,700,000

Notification of Issue, Conversion or Payment up of Unquoted 5 / 7

 

 


Exhibit 99.1

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_10.jpg 

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

 

Part 4 - +Securities on issue

Following the issue, conversion or payment up of the +securities the subject of this application, the +securities of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +Securities (Total number of each +class of +securities quoted)

Total number of securities on issue

ASX +security code and description

BNO : ORDINARY FULLY PAID 1,353,350,744

4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)

Total number of securities on issue

ASX +security code and description

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 86,756,617

BNOAS : WARRANTS 142,000,000

Notification of Issue, Conversion or Payment up of Unquoted 6 / 7

 

 


Exhibit 99.1

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_11.jpg 

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

 

Part 5 - Other Listing Rule requirements

5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue

did not need any security holder approval under Listing Rule 7.1?

 

https://cdn.kscope.io/3b2fce708f5e35c40752096422e62cd4-img65882896_12.jpgYes

5.1a Select the number of the applicable exception in Listing Rule 7.2
13